Sierralta O E, Scott D M
University of Nebraska, Omaha.
Am Pharm. 1995 May;NS35(5):36-8. doi: 10.1016/s0160-3450(15)30142-2.
This field study tested the ability of pharmacists to counsel patients with diabetes mellitus on the contraindicated use of a decongestant. The study was modeled after a 1969 study conducted by Knapp et al. Our simulation used a patient with diabetes who questioned pharmacists initially about proper insulin storage and then asked about the use of Contac (phenylpropanolamine) capsules, which carry a prominent label warning against use by diabetic patients. A research assistant, posing as the patient, interviewed pharmacists at 36 community pharmacies in a midwestern metropolitan area. Eleven of the pharmacists (30.5%) failed to warn the patient about the contraindication, compared with 83% in the earlier study.
这项实地研究测试了药剂师就充血药的禁忌使用向糖尿病患者提供咨询的能力。该研究仿照了Knapp等人在1969年进行的一项研究。我们的模拟中使用了一名糖尿病患者，该患者最初向药剂师询问胰岛素的正确储存方法，然后又询问了康泰克（去甲麻黄碱）胶囊的使用情况，这种胶囊带有明显的标签，警告糖尿病患者不要使用。一名研究助理假扮患者，采访了中西部一个大都市地区36家社区药房的药剂师。11名药剂师（30.5%）没有就该禁忌向患者发出警告，而早期研究中的这一比例为83%。
